A New Therapy for Liver Cirrhosis by Transplantation of Proliferative Enbrional Hepatocyte

增殖胚肝细胞移植治疗肝硬化的新疗法

基本信息

  • 批准号:
    06454358
  • 负责人:
  • 金额:
    $ 5.06万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

[Purpose] The purpose of this study is to establish a therapy for the liver cirrhosis by a transplantation of proliferative hepatocyte and administration of antisense for mRNA of collagenase. [Materials and Methods] Process of the study were as followed. A) Model of liver cirrhosis is made in mouse and rat and mechanism of fibrosis is analized. B) Hybridomas of hepatic cells whitch can proliferate are made with embrional hepatocytes and parenchymal and nonparenchymal hepatocytes. C) The hybridomas are transplanted into the cirrhotic liver and antisense for the collagenese mRNA is also injected the liver. Conditions of regenerating normal liver are studied. [Results] We made liver cirrhosis using CC1_4 and examined hidroxyprolil activity during changing liver cirrhosis in rats. And we developped a new device for selective cell fusion by Laser devic. Using this device we tried to make hybridoma of parenchymal hepatocyte and embrional hepatocyte, which can proliferate. We prepared HVJ liposome using Sendai virus and phospholipid for transfection of antisense of collagenase-mRNA.Studies of investigation in analysis of fibrosing process of liver were still remained.
[目的]建立肝细胞移植联合胶原酶反义基因治疗肝硬化的新方法。[材料与方法]研究过程如下。A)建立小鼠和大鼠肝硬化模型,分析肝纤维化的机制。B)用胚胎肝细胞和实质和非实质肝细胞制备可增殖的肝细胞杂交瘤。C)将杂交瘤移植到患肝中,并将胶原mRNA的反义基因也注射到肝中。研究了正常肝再生的条件。[结果]采用四氯化碳(CCl_4)诱导大鼠肝硬化模型,并在肝硬化过程中检测羟脯氨酸的活性。并研制了一种新型的激光选择性细胞融合装置。利用该装置,我们尝试了制备具有增殖能力的肝实质细胞和胚性肝细胞杂交瘤。我们用仙台病毒和磷脂制备了HVJ脂质体,用于转染胶原酶-mRNA的反义核酸,并对肝纤维化过程进行了分析。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Itagaki H,Doi H,Ohkohchi N,et al.: "Laser Device for Cellfusion (Viability and Function of Hybridoma)" Artificial Organ. (in press).
Itagaki H,Doi H,Ohkohchi N,et al.:“细胞融合激光装置(杂交瘤的活力和功能)”人工器官。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Itagaki H,Ohkohchi N,Satomi S,et al.: "A New Cell Fusion Method by Laser" Pharmacology and Clinics. 6. 1535-1538 (1996)
Itagaki H,Ohkohchi N,Satomi S,et al.:“一种新的激光细胞融合方法”药理学和临床。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Itagaki H,Doi H,Ohkohchi N,et al.: "Selective Cellfusion Method by Laser Device" Acta Histochemia et Cytochemia. 29. 750-751 (1996)
Itagaki H,Doi H,Ohkohchi N,et al.:“激光装置选择性细胞融合法”组织化学与细胞化学学报。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seya K,Ohkohchi N,Mori S: "Changes in Ability of ATP synthesis in the Mitochondrial Membrane in the Rat Liver Injured by Carbon Tetrachloride" Tohoku J Exp Med. 178. 425-430 (1996)
Seya K,Ohkohchi N,Mori S:“四氯化碳损伤的大鼠肝脏线粒体膜中 ATP 合成能力的变化”Tohoku J Exp Med。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAGUCHI Yoshio其他文献

TAGUCHI Yoshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAGUCHI Yoshio', 18)}}的其他基金

New Technique for Producing Hybridoma and Gene Transfection Using Laser Iradiation
利用激光照射生产杂交瘤和基因转染的新技术
  • 批准号:
    10557107
  • 财政年份:
    1998
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Treamtent of liver cirrhosis using inoculation of proliferative hepatocyte and gene transduction of antisense for mRNA of collagenase inhibitor.
利用增殖肝细胞接种和胶原酶抑制剂mRNA反义基因转导治疗肝硬化。
  • 批准号:
    08457293
  • 财政年份:
    1996
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Defining the role of G6pc-high hepatocyte and Slc25a44 in metabolism via spatial transcriptome
通过空间转录组定义 G6pc-high 肝细胞和 Slc25a44 在代谢中的作用
  • 批准号:
    22KK0271
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Primary hepatocyte and engineered iPSC-derived hepatocyte-like cell transplantation to treat alpha-1 antitrypsin deficiencyassociated liver disease
原代肝细胞和工程 iPSC 衍生的肝细胞样细胞移植治疗 α-1 抗胰蛋白酶缺乏相关的肝病
  • 批准号:
    10607039
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Development of a Microphysiological System for Transvascular Drug Delivery to 3D Hepatocyte Spheroids
开发用于 3D 肝细胞球体经血管药物输送的微生理系统
  • 批准号:
    23K19214
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH
确定 Ube4A 调节 NAFLD/NASH 的肝细胞特异性机制
  • 批准号:
    10587876
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Integrative analysis of metabolomics transcriptomics and proteomics to study mechanisms that regulate lentiviral vector hepatocyte transduction
代谢组学、转录组学和蛋白质组学的综合分析,研究调节慢病毒载体肝细胞转导的机制
  • 批准号:
    BB/Y513532/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Training Grant
Integrative analysis of metabolomics, transcriptomics and proteomics to study mechanisms that regulate lentiviral vector hepatocyte transduction
代谢组学、转录组学和蛋白质组学的综合分析,研究慢病毒载体肝细胞转导的调节机制
  • 批准号:
    2891574
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Studentship
Characterizing zonated hepatocyte sexual dimorphism and its role in fatty liver disease
分区肝细胞性别二态性的特征及其在脂肪肝疾病中的作用
  • 批准号:
    10588098
  • 财政年份:
    2023
  • 资助金额:
    $ 5.06万
  • 项目类别:
Roles of the Lysine Methyl Transferase (KMT) 2D in hepatocyte cell identity and hepatocellular carcinoma (HCC) progression
赖氨酸甲基转移酶 (KMT) 2D 在肝细胞细胞识别和肝细胞癌 (HCC) 进展中的作用
  • 批准号:
    472010
  • 财政年份:
    2022
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Fellowship Programs
Roles of the Lysine Methyl Transferase (KMT) 2d in hepatocyte identity
赖氨酸甲基转移酶 (KMT) 2d 在肝细胞识别中的作用
  • 批准号:
    567766-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 5.06万
  • 项目类别:
    Postdoctoral Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了